Applied DNA Sciences, Inc.
APDN
$3.75
-$0.34-8.31%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 891.20K | 779.70K | 2.92M | 4.41M | 5.26M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 891.20K | 779.70K | 2.92M | 4.41M | 5.26M |
| Cost of Revenue | 660.10K | 700.70K | 1.65M | 2.60M | 2.89M |
| Gross Profit | 231.10K | 79.00K | 1.27M | 1.81M | 2.38M |
| SG&A Expenses | 3.08M | 3.31M | 3.29M | 3.52M | 2.63M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.68M | 4.95M | 5.78M | 7.11M | 6.48M |
| Operating Income | -3.79M | -4.17M | -2.86M | -2.70M | -1.22M |
| Income Before Tax | -1.13M | -3.62M | -3.11M | 551.20K | -3.84M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.13M | -3.62M | -3.11M | 551.20K | -3.84M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 25.20K | 23.40K | 14.40K | 37.20K | 900.00 |
| Net Income | -1.11M | -3.59M | -3.10M | 588.30K | -3.84M |
| EBIT | -3.79M | -4.17M | -2.86M | -2.70M | -1.22M |
| EBITDA | -3.49M | -3.84M | -2.51M | -2.36M | -880.10K |
| EPS Basic | -1.73 | -5.29 | -4.80 | 0.91 | -5.95 |
| Normalized Basic EPS | -1.00 | -3.29 | -2.99 | 0.59 | -3.72 |
| EPS Diluted | -1.80 | -5.29 | -4.80 | 0.91 | -6.00 |
| Normalized Diluted EPS | -1.00 | -3.29 | -2.99 | 0.59 | -3.72 |
| Average Basic Shares Outstanding | 683.70K | 678.40K | 645.40K | 645.40K | 645.40K |
| Average Diluted Shares Outstanding | 683.70K | 678.40K | 645.40K | 645.40K | 645.40K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
